“In-Bore” MRI-Guided Prostate Biopsy for Prostate Cancer Diagnosis: Results from 140 Consecutive Patients | Zendy

Daniele D’Agostino | Zendy; Daniele Romagnoli | Zendy; Marco Giampaoli | Zendy; Federico Mineo Bianchi | Zendy; Paolo Corsi | Zendy; Alessandro Del Rosso | Zendy; Riccardo Schiavina | Zendy; Eugenio Brunocilla | Zendy; Walter Artibani | Zendy; Angelo Porreca | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

“In-Bore” MRI-Guided Prostate Biopsy for Prostate Cancer Diagnosis: Results from 140 Consecutive Patients

Author(s) -

Daniele D’Agostino,

Daniele Romagnoli,

Marco Giampaoli,

Federico Mineo Bianchi,

Paolo Corsi,

Alessandro Del Rosso,

Riccardo Schiavina,

Eugenio Brunocilla,

Walter Artibani,

Angelo Porreca

Publication year - 2020

Publication title -

current urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.476

H-Index - 13

eISSN - 1661-7657

pISSN - 1661-7649

DOI - 10.1159/000499264

Subject(s) - medicine , prostate cancer , prostate , radiology , biopsy , prostate biopsy , cancer , urology

Transrectal ultrasound-guided biopsy (TRUS-GB) is the current reference standard procedure for diagnosis of prostate cancer (PCa) but this procedure has limitations related to the low detection rate (DR) described in the literature. The aim of the study was to evaluate the DR efficiency, and complication rate in a pure "in-bore" magnetic resonance imaging-guided biopsy (MRI-GB) series according to the Prostate Imaging Reporting and Data System, version 2 (PI-RADS v2).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research